Changes

Jump to navigation Jump to search
585 bytes added ,  22:35, 30 June 2023
no edit summary
Line 7: Line 7:     
=[[Anemia]]=
 
=[[Anemia]]=
 +
*Micro: Thalassemia (Mentzer Index < 13: MCV/RBC), Iron (RDW high), Chronic inflammation (ESR, CRP), Lead (serum level), Sideroblastic
 +
*Normo:
 +
** Non-Hemolytic (retic count ≤ 2%, normal LDH/haptoglobin/RDW): Chronic inflammation, Iron, CKD, Aplastic
 +
** Hemolytic (retic count > 2%, elevated LDH, low haptoglobin, elevated RDW):
 +
*** Intrinsic: MEH (HS/PNH, G6PD/Pyruvate kinase, SCD/HbC)
 +
*** Extrinsic: MAMI
 +
*Macro:
 +
** Megaloblastic: B12 Folate Fanconi
 +
** Non-Megaloblastic: Alcohol Liver disease
    
=Thrombocytopenia=
 
=Thrombocytopenia=
Line 28: Line 37:  
*Dx: Bone marrow biopsy showing >10% clonal plasma cells + end organ damage (CRAB) OR >60% clonal plasma cells without end organ damage. M-spike on SPEP (also shows up in smoldering myeloma). Bone scan shows punched out lesions. Hyperviscosity syndrome when there is monoclonal IgM, this leads to impaired platelet function and epistaxis/gingival bleeding (overall more common in Waldenstrom's macroglobulinemia). β2 microglobulin is a prognostic marker.
 
*Dx: Bone marrow biopsy showing >10% clonal plasma cells + end organ damage (CRAB) OR >60% clonal plasma cells without end organ damage. M-spike on SPEP (also shows up in smoldering myeloma). Bone scan shows punched out lesions. Hyperviscosity syndrome when there is monoclonal IgM, this leads to impaired platelet function and epistaxis/gingival bleeding (overall more common in Waldenstrom's macroglobulinemia). β2 microglobulin is a prognostic marker.
 
*Tx: Autologous Stem Cell Transplant or chemotherapy
 
*Tx: Autologous Stem Cell Transplant or chemotherapy
 +
 +
 +
https://www.ohsu.edu/knight-cancer-institute/thomas-deloughery-mds-famous-handouts

Navigation menu